Concepedia

Author

Aldona Wierzbicka

Children's Memorial Health InstituteORCID

Also Known As

A WIERZBICKA, A Wierzbicka, A. Wierzbicka, A. Wierzbicka-Rucinska, Aldona Wierzbicka, Aldona Wierzbicka-Rucińska, Aldona Wierzbicka-rucinska, Aldona Wierzbicka‐Rucińska, M Litwin

103

Publications

2K

Citations

24

H-Index

70

Concepts

All Affiliations

Children's Memorial Health InstituteNicolaus Copernicus UniversityCollegium Medicum in BydgoszczMedical University of BiałystokUniversitat Rovira i Virgili
AW

About

Aldona Wierzbicka is an author at Children's Memorial Health Institute specializing in medicine, pediatrics, and hypertension.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

833

2

Health Sciences

7

7

259

3

Public Health

3

3

73

4

Clinical Nutrition

3

3

159

5

Child Development

1

1

32

Aldona Wierzbicka

×

44

Publications

1.8K

Citations

24

H-Index

YearCitations

Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension

Mieczysław Litwin, Anna Niemirska, Joanna Śladowska,

Pediatric Nephrology

2006

198

Regression of target organ damage in children and adolescents with primary hypertension

Mieczysław Litwin, Anna Niemirska, Joanna Śladowska-Kozłowska,

Pediatric Nephrology

2010

189

Intima-media thickness and arterial elasticity in hypertensive children: controlled study

Mieczysław Litwin, Justyna Trelewicz, Zbigniew T. Wawer,

Pediatric Nephrology

2004

135

Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Wojciech Jańczyk, Dariusz Lebensztejn, Aldona Wierzbicka,

The Journal of Pediatrics

2015

122

Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases

Ewa Pronicka, Elżbieta Ciara, Paulina Halat,

Journal of Applied Genetics

2017

92

Metabolic Abnormalities, Insulin Resistance, and Metabolic Syndrome in Children With Primary Hypertension

Mieczysław Litwin, Joanna Śladowska, Jolanta Antoniewicz,

American Journal of Hypertension

2007

87

Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.

Dariusz Lebensztejn, Aldona Wierzbicka, Piotr Socha,

Acta Biochimica Polonica

2011

71

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

Wojciech Jańczyk, Piotr Socha, Dariusz Lebensztejn,

BMC Pediatrics

2013

64

Kidney length normative values in children aged 0–19 years — a multicenter study

Łukasz Obrycki, Jędrzej Sarnecki, Marianna Lichosik,

Pediatric Nephrology

2021

64

Inflammatory activation in children with primary hypertension

Mieczysław Litwin, Jacek Michałkiewicz, Anna Niemirska,

Pediatric Nephrology

2010

62

Page 1